I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients
Brief description of study
A trial to compare different investigational agents for their ability to improve clinical outcomes n severely ill patients with COVID-19 pneumonia.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
-
Conditions:
COVID-19 pneumonia,Covid-19 Pnemonia
-
Age: Between 18 Years - 99 Years
-
Gender: All
Male and Female Age 18 and over Covid-19 Pneumonia
Updated on
09 Mar 2024.
Study ID: 843758
If you need assistance finding a non-cancer clinical research study or if you have any questions, please email psom-ocr@pobox.upenn.edu
For cancer trials contact EmergingMed: 1-855-216-0098 or PennCancerTrials@emergingmend.com
